Bio-Techne (TECH) stock fell due to funding challenges in the biotech sector.

From Yahoo Finance: 2025-05-07 09:54:00

Mairs & Power released their first quarter 2025 investor letter, with the stock market reaching a record high in February but falling in March due to tariff uncertainty. The fund ended the quarter up 0.04%, outperforming benchmark indexes and Morningstar peer group. The fund’s top five holdings for 2025 are highlighted, including Bio-Techne Corporation. Bio-Techne Corporation, with a market cap of $7.544 billion, develops life science products. Their stock closed at $47.72 per share on May 6, 2025. Mairs & Power added to their Bio-Techne position despite recent underperformance due to funding challenges in the biotech sector.

Bio-Techne Corporation is not among the 30 most popular stocks among hedge funds, with 24 hedge fund portfolios holding it at the end of the fourth quarter. In the second quarter of fiscal 2025, the company generated $297 million in revenues, up 9% year-over-year. While Bio-Techne has investment potential, the focus is on AI stocks for higher returns in a shorter timeframe. An AI stock with promising potential and a low valuation is highlighted in a report for investors to consider.



Read more at Yahoo Finance: Bio Techne (TECH) Fell on Negative Funding Environment